Orilissa
NDC 0074-0038, Elagolix, tablet, film coated, from AbbVie Inc..
- Product NDC
- 0074-0038
- Status
- Listed
- Labeler
- AbbVie Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA210450
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0074-0038 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ELAGOLIX SODIUM150 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Decreased GnRH Secretion [PE]; Gonadotropin Releasing Hormone Receptor Antagonist [EPC]; Gonadotropin Releasing Hormone Receptor Antagonists [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0074-0038-07 | 00074003807 | 1 BLISTER PACK in 1 CARTON (0074-0038-07) / 7 TABLET, FILM COATED in 1 BLISTER PACK |
| 0074-0038-28 | 00074003828 | 4 BLISTER PACK in 1 CARTON (0074-0038-28) / 7 TABLET, FILM COATED in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a86757b3-09c5-fd3b-1223-244e94f50a66NADAC price for package 00074003828
GET /v1/drugs/nadac/00074003828
Use it
Look up 0074-0038 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0074-0038 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0074-0038. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.